| Authors: |
Ciesla AA; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Eagle Health Analytics, San Antonio, Texas; Westat and the Commissioned Corps of the U.S. Public Health Service, Rockville, Maryland; HealthPartners Institute, Minneapolis, Minnesota; the Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Salt Lake City, Utah; the Kaiser Permanente Center for Health Research, Portland, Oregon; the Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California; the Indiana University School of Medicine, the Regenstrief Institute Center for Biomedical Informatics, the Richard M. Fairbanks School of Public Health, and the Department of Pediatrics, School of Medicine, Indiana University, Indianapolis, Indiana; the University of Colorado School of Medicine, Aurora, Colorado; and the Department of Biomedical Informatics, Columbia University Irving Medical Center, and NewYork-Presbyterian Hospital, New York, New York., Lazariu V, Watts JA, Vazquez-Benitez G, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva M, Sheffield T, Bride D, Van Otterloo J, Arndorfer J, Naleway AL, Koppolu P, Fireman B, Hansen J, Timbol J, Dixon BE, Rogerson C, Fadel W, Barron MA, Mayer D, Chavez C, Zhuang Y, Cheung A, Reichle L, Natarajan K, Payne AB, Link-Gelles R, Zerbo O |
